Xponance Inc. has a $4.33 million position in Corteva, Inc. (NYSE:CTVA)

Xponance Inc. has sold its interest in shares of Corteva, Inc. (NYSE:CTVA – Free Report) increased 3.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 90,297 shares of the company, after acquiring an additional 3,284 shares during the quarter. The interests of Xponance Inc. in Corteva were worth $4,327,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. CVA Family Office LLC acquired a new stake in shares of Corteva in the fourth quarter worth approximately $25,000. BKM Wealth Management LLC bought a new stake in Corteva in the fourth quarter worth approximately $27,000. NewSquare Capital LLC increased its position in Corteva by 70.6% during the third quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock valued at $28,000 after purchasing an additional 226 shares during the period. Glass Jacobson Investment Advisors llc increased its holdings in Corteva by 234.3% during the third quarter. Glass Jacobson Investment Advisors LLC now owns 555 shares of the company’s stock worth $28,000 after purchasing an additional 389 shares during the last quarter. Finally, Cornerstone Planning Group LLC acquired a new position in shares of Corteva in the second quarter worth approximately $28,000. 81.54% of the shares are held by institutional investors.

Analysts set new price targets

CTVA has been the subject of a number of analyst reports. JPMorgan Chase & Co. reissued a “neutral” rating and set a target price of $57.00 (down from $58.00 previously) on shares of Corteva in a research note on Friday, April 12. Wells Fargo & Company lifted their price objective on Corteva from $54.00 to $65.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. TheStreet upgraded Corteva from a ‘c+’ rating to a ‘b-‘ rating in a research report on Tuesday, February 27th. Royal Bank of Canada raised their target price on Corteva from $56.00 to $64.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Finally, UBS Group lowered their price target on Corteva from $65.00 to $64.00 and set a “buy” rating on the stock in a report on Thursday, January 11. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and an average price target of $63.29.

Check out our latest analysis on Corteva

Corteva Price Performance

Shares of NYSE CTVA opened at $54.80 on Friday. The stock has a market cap of $38.30 billion, a price-to-earnings ratio of 53.73, a PEG ratio of 1.41 and a beta of 0.77. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $62.10. The company’s 50-day simple moving average is $55.23 and its 200-day simple moving average is $50.30.

Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.09. Corteva had a return on equity of 7.43% and a net margin of 4.27%. The company had revenue of $3.71 billion for the quarter, compared to analyst estimates of $3.54 billion. In the same quarter last year, the company posted earnings per share of $0.16. As a group, research analysts expect Corteva, Inc. will post a profit per share of 2.84 for the current financial year.

Corteva announces dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 15. A dividend of $0.16 was paid to known shareholders on Friday, March 1. The ex-dividend date was Thursday, February 29. This represents a dividend of $0.64 annually and a yield of 1.17%. Corteva’s dividend payout ratio (DPR) is 62.75%.

Corteva profile

(Free report)

Corteva, Inc operates in the agricultural industry. It operates through two segments: Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that deliver optimal yields for farms. It offers trait technologies that improve resistance to weather, diseases, insects and herbicides used to control weeds, as well as food and nutritional characteristics.

Read further

Would you like to see which other hedge funds hold CTVA? Visit HoldingsChannel.com for the latest 13F filings and insider transactions for Corteva, Inc. (NYSE:CTVA – Free Report).

Quarterly Institutional Ownership for Corteva (NYSE:CTVA)

Receive daily news and reviews for Corteva – Enter your email address below to receive a daily digest of the latest news and analyst ratings for Corteva and related companies with MarketBeat.com’s FREE daily email newsletter.